Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

98.23
Delayed Data
As of Aug 28
 +0.03 / +0.03%
Today’s Change
21.84
Today|||52-Week Range
110.68
+158.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Operating ActivitiesNet Income / Starting Line3.8M12.7M98.9M8.9M
 
 
 
 
 
Depreciation575.0K600.0K974.0K663.0K
 
 
 
 
 
Total Other Cash Flow4.6M5.1M4.4M5.1M
 
 
 
 
 
Funds From Operations9.2M18.6M16.5M20.5M
 
 
 
 
 
Funds From/For Other Operating Expenses2.5M3.5M-1.8M9.5M
 
 
 
 
 
Net Cash Flow - Operating Activities6.7M15.1M18.3M10.9M
 
 
 
 
 
 
InvestingIncrease In Investments-21.1M-28.0M-26.8M-42.7M
 
 
 
 
 
Decrease In Investments12.2M10.0M13.6M50.3M
 
 
 
 
 
Capital Expenditures-1.1M-736.0K-3.0M-1.9M
 
 
 
 
 
Net Assets From Acquisitions -15.7M0.000.000.00
 
 
Net Cash Flow Investing-25.8M-18.7M-16.2M5.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale2.1M6.1M2.7M4.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00606.0K81.0K
 
 
 
Other Uses - Financing0.000.001.8M3.5M
 
 
 
Net Cash Flow - Financing2.1M6.1M1.5M1.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-307.0K-467.0K-692.0K167.0K
 
 
 
 
 
 
Net Change In Cash-17.0M2.5M3.6M17.9M